Kyle Amber to Antibodies, Monoclonal, Murine-Derived
This is a "connection" page, showing publications Kyle Amber has written about Antibodies, Monoclonal, Murine-Derived.
Connection Strength
1.457
-
The controversy of hepatitis C and rituximab: A multidisciplinary dilemma with implications for patients with pemphigus. Indian J Dermatol Venereol Leprol. 2016 Mar-Apr; 82(2):182-3.
Score: 0.518
-
Private and public coverage policies for rituximab in the treatment of immunobullous disease in the United States. J Am Acad Dermatol. 2015 Aug; 73(2):337-8.
Score: 0.498
-
Autoreactive T cells in the immune pathogenesis of pemphigus vulgaris. Exp Dermatol. 2013 Nov; 22(11):699-704.
Score: 0.441